About Index Trending news
Analyze
Top 50 Pricing
Savara Pharmaceuticals

Savara Pharmaceuticals

Work at Savara Pharmaceuticals? Add yourself to this profile

Savara Pharmaceuticals

Savara Pharmaceuticals develops an inhaled antibiotic for MRSA infection inCystic Fibrosis

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$20,000,000
Venture capital
$10,000,000
Boutique investment bank
Employees

Team size

2
Locations
HQ
Xconomy

Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates

$20,000,000 Venture capital (Series C)
FinSMEs , Xconomy

Savara Pharmaceuticals Closes $20M Series C Financing

Health Funding